Downregulation of Id2 increases chemosensitivity of glioma

Tumor Biology

Volumn 36, Issue 6, 2015, Pages 4189-4196

  Zhao, ZhenYu ^a   He, Hua ^b   Wang, ChunLin ^c   Tao, BangBao ^b   Zhou, Hui ^d   Dong, Yan ^b   Xiang, Jingjing ^e   Wang, Lei ^f   Luo, Chun ^b   Lu, YiCheng ^b   Yu, Xinguang ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c The 105th Hospital of PLA   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

^e SUZHOU INSTITUTE OF BIOMEDICAL ENGINEERING AND TECHNOLOGY   (China)

^f HUNAN NORMAL UNIVERSITY   (China)

Author keywords

Chemosensitivity; Glioblastoma; Id2; RNA interference

Indexed keywords

CASPASE 3; FLUORESCEIN ISOTHIOCYANATE; INHIBITOR OF DIFFERENTIATION 2; SEMUSTINE; TEMOZOLOMIDE; TENIPOSIDE; DACARBAZINE; ID2 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CHEMOSENSITIVITY; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; GENETIC ANALYSIS; GLIOMA; GLIOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; ID2 GENE; MAJOR CLINICAL STUDY; MOLECULARLY TARGETED THERAPY; MTT ASSAY; ONCOGENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TREATMENT OUTCOME; UPREGULATION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; BIOSYNTHESIS; CELL PROLIFERATION; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DACARBAZINE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 2; RNA INTERFERENCE;

EID: 84938988147     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3055-5     Document Type: Article

References (20)

1. Zhao J, He H, Zhou K, Ren Y, Shi Z, Wu Z, et al. Neuronal transcription factors induce conversion of human glioma cells to neurons and inhibit tumorigenesis. PLoS One. 2012;7:e41506.
2. Tao BB, He H, Shi XH, Wang CL, Li WQ, Li B, et al. Upregulation of USP2a and FASN in gliomas correlates strongly with glioma grade. J Clin Neurosci. 2013;20:717–20.
3. Galanis E, Buckner J. Chemotherapy for high-grade gliomas. Br J Cancer. 2000;82:1371–80.
4. Zhao Z, Liu Y, He H, Chen X, Chen J, Lu YC. Candidate genes influencing sensitivity and resistance of human glioblastoma to semustine. Brain Res Bull. 2011;86:189–94.
5. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell. 1990;61:49–59.
6. Mariño G, Niso-Santano M, Baehrecke EH, Kroemer G. Self-consumption: the interplay of autophagy and apoptosis. Nat Rev Mol Cell Biol. 2014;15:81–94.
7. Norton JD, Deed RW, Craggs G, Sablitzky F. Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol. 1998;8:58–65.
8. Yokota Y, Mori S. Role of Id family proteins in growth control. J Cell Physiol. 2002;190:21–8.
9. Trabosh VA, Divito KA, D Aguda B, Simbulan-Rosenthal CM, Rosenthal DS. Sequestration of E12/E47 and suppression of p27KIP1 play a role in Id2-induced proliferation and tumorigenesis. Carcinogenesis. 2009;30:1252–9.
10. Lasorella A, Rothschild G, Yokota Y, Russell RG, Iavarone A. Id2 mediates tumor initiation, proliferation, and angiogenesis in Rb mutant mice. Mol Cell Biol. 2005;25:3563–74.
11. Meng Y, Gu C, Wu Z, Zhao Y, Si Y, Fu X, et al. Id2 promotes the invasive growth of MCF-7 and SKOV-3 cells by a novel mechanism independent of dimerization to basic helix-loop-helix factors. BMC Cancer. 2009;9:75.
12. Coppe JP, Itahana Y, Moore DH, Bennington JL, Desprez PY. Id1 and Id2 proteins as molecular markers for human prostate cancer progression. Clin Cancer Res. 2004;10:2044–51.
13. Han W, Wu Z, Zhao Y, Meng Y, Si Y, Yang J, et al. FHL2 interacts with and acts as a functional repressor of Id2 in human neuroblastoma cells. Nucleic Acids Res. 2009;37:3996–4009.
14. Stallone G, Infante B, Pontrelli P, Ranieri E, Loverre A, Schena A, et al. ID2-VEGF-related pathways in the pathogenesis of Kaposi’s sarcoma: a link disrupted by rapamycin. Am J Transplant. 2009;9:558–66.
15. Spiegel BM, Esrailian E, Laine L, Chamberlain MC. Clinical impact of adjuvant chemotherapy in glioblastoma multiforme: a meta-analysis. CNS Drugs. 2007;21:775–87.
16. Wall NR, Shi Y. Small RNA: can RNA interference be exploited for therapy? Lancet. 2003;362:1401–3.
17. Pommier Y, Sordet O, Antony S, Hayward RL, Kohn KW. Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks. Oncogene. 2004;23:2934–49.
18. Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: a link between cancer genetics and chemotherapy. Cell. 2002;108:153–64.
19. Cao Y, Liu X, Zhang W, Deng X, Zhang H, Liu Y, et al. TGF-beta repression of Id2 induces apoptosis in gut epithelial cells. Oncogene. 2009;28:1089–98.
20. Cohen GM. Caspases: the executioners of apoptosis. Biochem J. 1997;326:1–16.